FDA Withdraws Exparel Warning Letter, Settles Free-Speech Suit By Pacira

(December 16, 2015, 2:33 PM EST) -- NEW YORK — Pacira Pharmaceuticals Inc. on Dec. 14 agreed to dismiss its free-speech lawsuit against the Food and Drug Administration for the marketing of the local anesthetic Exparel after the...
To view the full article, register now.